CD4 memory T cells divide poorly in response to antigen because of their cytokine profile.
Immunological memory is a hallmark of adaptive immunity, and understanding T cell memory will be central to the development of effective cell-mediated vaccines. The characteristics and functions of CD4 memory cells have not been well defined. Here we demonstrate that the increased size of the secondary response is solely a consequence of the increased antigen-specific precursor frequency within the memory pool. Memory cells proliferated less than primary responding cells, even within the same host. By analyzing the entry of primary and memory cells into the cell cycle, we found that the two populations proliferated similarly until day 5; after this time, fewer of the reactivated memory cells proliferated. At this time, fewer of the reactivated memory cells made IL-2 than primary responding cells, but more made IFNgamma. Both these factors affected the low proliferation of the memory cells, because either exogenous IL-2 or inhibition of IFNgamma increased the proliferation of the memory cells.
MacLeod
Megan K L
MK
Howard Hughes Medical Institute and Department of Immunology, National Jewish Medical and Research Center and University of Colorado Health Science Center, Denver, CO 80206, USA. macleodm@njc.org
McKee
Amy
A
Crawford
Frances
F
White
Janice
J
Kappler
John
J
Marrack
Philippa
P
D000818:Animals; D000941:Antigens / Q000276:immunology*; D015496:CD4-Positive T-Lymphocytes / Q000166:cytology / Q000276:immunology* / Q000821:virology; D002455:Cell Division / Q000276:immunology; D002465:Cell Movement; D016207:Cytokines / Q000276:immunology*; D005260:Female; D007156:Immunologic Memory / Q000276:immunology*; D007371:Interferon-gamma / Q000276:immunology; D007376:Interleukin-2 / Q000276:immunology; D008213:Lymphocyte Activation / Q000276:immunology; D008216:Lymphocytic Choriomeningitis / Q000276:immunology; D008217:Lymphocytic choriomeningitis virus / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D013997:Time Factors
D000941:Antigens; D016207:Cytokines; D007376:Interleukin-2; D007371:Interferon-gamma
Infect Immun. 2006 Nov;74(11):6252-63
16966404
Science. 2007 Oct 5;318(5847):116-20
17916739
Eur J Immunol. 2003 Oct;33(10):2875-85
14515271
Nature. 2006 Jun 15;441(7095):890-3
16778891
Nat Med. 2006 Aug;12(8):955-60
16892038
J Immunol. 1998 Jul 1;161(1):367-74
9647245
J Immunol. 1999 Jan 15;162(2):766-73
9916697
J Exp Med. 2002 Oct 7;196(7):957-68
12370257
J Immunol. 2003 Dec 1;171(11):5727-35
14634080
J Exp Med. 2000 Jul 3;192(1):117-22
10880532
Eur J Immunol. 1995 Dec;25(12):3402-11
8566030
Cell. 2005 Jul 29;122(2):247-60
16051149
Nature. 2001 Mar 1;410(6824):101-5
11242050
Nat Immunol. 2005 Aug;6(8):793-9
16025119
J Immunol. 2006 Mar 1;176(5):3028-36
16493061
J Immunol. 2000 May 1;164(9):4551-7
10779756
Nat Med. 2001 Aug;7(8):913-9
11479623
J Immunol. 2006 Jul 15;177(2):869-76
16818741
Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9357-62
15197277
Cancer Res. 1962 Feb;22:254-65
14459709
Immunity. 2007 Aug;27(2):203-13
17707129
J Immunol. 2007 Aug 15;179(4):2115-25
17675470
J Exp Med. 2006 Apr 17;203(4):897-906
16549596
Nature. 1999 Oct 14;401(6754):708-12
10537110
Immunity. 1998 Jun;8(6):675-82
9655481
Immunol Rev. 2006 Jun;211:154-63
16824125
J Exp Med. 2002 Mar 4;195(5):657-64
11877489
J Immunol. 2007 Mar 1;178(5):2646-50
17312104
J Exp Med. 2007 Jan 22;204(1):65-71
17227909
Annu Rev Immunol. 2001;19:23-45
11244029
PLoS Pathog. 2008 Apr 11;4(4):e1000041
18404208
Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6341-6
17400753
Annu Rev Immunol. 2007;25:171-92
17129182
Science. 2006 Apr 7;312(5770):114-6
16513943
Nat Rev Immunol. 2005 Feb;5(2):101-11
15662368
J Exp Med. 2006 Apr 17;203(4):1045-54
16567390
Curr Opin Immunol. 2006 Jun;18(3):255-64
16632337
Nat Rev Immunol. 2003 Apr;3(4):269-79
12669018
J Virol. 2003 Feb;77(4):2522-9
12551990
J Immunol. 2005 Nov 1;175(9):5624-8
16237051